Vorsitz/Chair: Ralf P. Brandes (Frankfurt am Main), Michael Schwarzer (Jena)
Agenda
14:30
(V1221)
Nitrated fatty acids as a promising pharmacological treatment in abdominal aortic aneurysm
P. Arkenberg (Köln)
Zum Abstract
14:37
Diskussion
14:41
(V1222)
PI 3-Kinase vermittelte Inaktivierung von FOXO1 in glatten Gefäßmuskelzellen hemmt Entstehung und Progression abdominaler aortaler Aneurysmata
M. Vantler (Köln)
Zum Abstract
14:48
Diskussion
14:52
(V1223)
Hemoglobin-scavenging CD163+/HO-1+ macrophages lose their protective effect in patients with AAA
B. Hamann (Dresden)
Zum Abstract
14:59
Diskussion
15:03
(V1224)
Characterization of a large animal model of abdominal aortic aneurysm (AAA) and its comparison with human and murine AAA
T. Uebing (Düsseldorf)
Zum Abstract
15:10
Diskussion
15:14
(V1225)
Locoregional Immune Response in Thoracic and Abdominal Aortic Aneurysms
V. Niemann (Düsseldorf)
Zum Abstract
15:21
Diskussion
15:25
(V1226)
Significant induction of PD-ECGF and E-selectin in remodeled tunica media of thoracic aortic aneurysm and dissection tissues indicates a preventive effect of cimetidine
C. Dittfeld (Dresden)
Zum Abstract
15:32
Diskussion
15:36
(V1227)
Sphingosine-1-phosphate in the pathogenesis of human and mouse aneurysms: a biomarker and causal player
N. H. Schröder (Düsseldorf)
Zum Abstract
15:43
Diskussion
15:47
(V1228)
The Role of Necroptosis in Marfan Syndrome-associated Thoracic Aortic Aneurysm Disease